Cholangiocarcinoma Clinical Trials in Chengdu, Sichuan
9 recruitingChengdu, Sichuan, China
Showing 1–9 of 9 trials
Recruiting
Phase 2
Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)
Intrahepatic Cholangiocarcinoma (Icc)HAICDurvalumab
West China Hospital25 enrolled1 locationNCT06859684
Recruiting
Phase 2
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
Advanced CholangiocarcinomaFGFR2 FusionsGene Rearrangement
Taiho Oncology, Inc.120 enrolled65 locationsNCT05727176
Recruiting
Phase 1Phase 2
PULSAR Combined With Immunotherapy and Chemotherapy
Cholangiocarcinoma
Wang Xin60 enrolled1 locationNCT07291947
Recruiting
Phase 1
A Study of GV20-0251 in Advanced or Refractory Solid Tumors
Endometrial CancerCholangiocarcinomaMelanoma+5 more
West China Hospital10 enrolled1 locationNCT07106827
Recruiting
Phase 2
Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma
Cholangiocarcinoma
West China Hospital51 enrolled1 locationNCT06438822
Recruiting
Phase 2
Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
Intrahepatic Cholangiocarcinoma
The First Affiliated Hospital with Nanjing Medical University33 enrolled3 locationsNCT06208462
Recruiting
Phase 2
DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma
Intrahepatic CholangiocarcinomaApatinibTransarterial Chemoembolization+1 more
Sichuan Cancer Hospital and Research Institute20 enrolled1 locationNCT04834674
Recruiting
Phase 2
Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer
Cholangiocarcinoma Non-resectable
West China Hospital65 enrolled1 locationNCT05978609
Recruiting
Not Applicable
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University168 enrolled13 locationsNCT04078230